* IRadimed Corp IRMD.OQ reported quarterly adjusted
earnings of
26 cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for earnings of
24 cents per share.
* Revenue rose 29.7% to $12.72 million from a year ago;
analysts
expected $12.60 million.
* IRadimed Corp's reported EPS for the quarter was 26
cents.
* The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* IRadimed Corp shares had risen by 16.5% this quarter and
lost 12.7% so far this year.
* The company reported quarterly net income of $3.24
million.
* Wall Street's median 12-month price target for IRadimed
Corp is
$46.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data July 29
at 05:00 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 0.24 0.26 Beat
Mar. 31 2022 0.21 0.22 Beat
Dec. 31 2021 0.21 0.33 Beat
Sep. 30 2021 0.17 0.23 Beat